COPD Management Guidelines

Patient Assessment and Treatment

• The American Thoracic Society recommends that patients with mild COPD who are symptomatic initiate short-acting bronchodilators as needed via an appropriate inhaler device 1
• For patients with moderate COPD, the American College of Chest Physicians suggests regular use of long-acting bronchodilator monotherapy, with long-acting muscarinic antagonists preferred for exacerbation prevention 1
• A corticosteroid trial should be performed in moderate COPD patients, with a positive response defined as an increase in lung function of 200 ml and 15% of baseline 1
• The American Journal of Respiratory and Critical Care Medicine recommends that patients with severe COPD receive combination therapy with LABA/LAMA, providing superior bronchodilation and exacerbation prevention compared to monotherapy 1
• For patients with severe COPD and low exacerbation risk, LAMA monotherapy or ICS + LABA combination therapy are alternatives 1
• The American Thoracic Society suggests that patients with FEV1 <50% predicted and ≥2 exacerbations in the previous year add ICS to LABA + LAMA combination therapy 1
• Consider adding ICS if blood eosinophil count ≥150-200 cells/µL or if asthma-COPD overlap syndrome is present 1
• Long-term oxygen therapy is indicated for patients with low oxygen levels, with the goal of maintaining oxygen saturation ≥90% during rest, sleep, and exertion 1
• The American Journal of Respiratory and Critical Care Medicine recommends that patients with very severe COPD consider referral for lung transplantation if the BODE index >7, FEV1 <15-20% predicted, or three or more severe exacerbations in the preceding year 2

Universal Interventions

• Smoking cessation is the single most important intervention for all COPD patients and should be strongly encouraged at every clinical encounter, according to the American College of Chest Physicians 1
• Nicotine replacement therapy and behavioral interventions increase success rates 1
• Active smoking cessation programs with nicotine replacement achieve higher sustained quit rates 1
• Pulmonary rehabilitation programs improve exercise tolerance and quality of life in patients with moderate to severe COPD, and should include physiotherapy, muscle training, nutritional support, and education 1
• Annual influenza vaccination is recommended for all COPD patients 1
• Pneumococcal vaccination may be considered, with revaccination every 5-10 years 1

Management of Acute Exacerbations

• Exacerbations are classified as mild, moderate, or severe, and treatment should be tailored accordingly, according to the American Journal of Respiratory and Critical Care Medicine 2
• Increase bronchodilator therapy and consider nebulizers if inhaler technique is inadequate 1
• Antibiotics are indicated when ≥2 of the following are present: increased breathlessness, increased sputum volume, purulent sputum 1
• Systemic corticosteroids improve lung function and shorten recovery time 1
• Non-invasive ventilation should be the first mode of ventilation for acute respiratory failure 2
• Maintenance therapy with long-acting bronchodilators should be initiated before hospital discharge 2

Critical Pitfalls to Avoid

• Beta-blocking agents should be avoided in COPD patients, according to the American College of Chest Physicians 1
• There is no evidence supporting prophylactic antibiotics given continuously or intermittently 1
• Theophyllines are of limited value in routine COPD management 1